FDC
|
FDC Last 5 Year Financial Ratios History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Operational & Financial Ratios | |||||
Earnings Per Share (Rs) | 16.39 | 18.74 | 11.70 | 12.82 | 17.85 |
CEPS(Rs) | 19.69 | 21.19 | 14.03 | 15.01 | 20.08 |
DPS(Rs) | 5.00 | - | - | - | - |
Book NAV/Share(Rs) | 140.11 | 128.81 | 119.47 | 115.92 | 102.73 |
Tax Rate(%) | 25.31 | 23.01 | 24.82 | 25.30 | 22.32 |
Margin Ratios | |||||
Core EBITDA Margin(%) | 14.93 | 16.93 | 13.57 | 16.12 | 24.46 |
EBIT Margin(%) | 16.63 | 20.02 | 14.24 | 18.59 | 28.65 |
Pre Tax Margin(%) | 16.42 | 19.82 | 14.02 | 18.39 | 28.40 |
PAT Margin (%) | 12.26 | 15.26 | 10.54 | 13.74 | 22.06 |
Cash Profit Margin (%) | 14.73 | 17.25 | 12.66 | 16.11 | 24.83 |
Performance Ratios | |||||
ROA(%) | 7.67 | 9.39 | 6.23 | 7.59 | 11.85 |
ROE(%) | 12.19 | 14.96 | 9.84 | 11.71 | 18.36 |
ROCE(%) | 16.52 | 19.62 | 13.27 | 15.78 | 23.74 |
Asset Turnover(x) | 0.63 | 0.62 | 0.59 | 0.55 | 0.54 |
Sales/Fixed Asset(x) | 2.01 | 2.04 | 1.91 | 1.70 | 1.57 |
Working Capital/Sales(x) | 3.01 | 2.66 | 2.58 | 2.16 | 1.88 |
Efficiency Ratios | |||||
Fixed Capital/Sales(x) | 0.50 | 0.49 | 0.52 | 0.59 | 0.64 |
Receivable days | 18.98 | 21.91 | 20.32 | 22.35 | 31.31 |
Inventory Days | 64.09 | 65.48 | 62.83 | 60.27 | 56.79 |
Payable days | 96.96 | 101.39 | 87.78 | 73.73 | 86.01 |
Valuation Parameters | |||||
PER(x) | 24.06 | 22.66 | 21.94 | 20.04 | 16.00 |
PCE(x) | 20.03 | 20.04 | 18.29 | 17.11 | 14.23 |
Price/Book(x) | 2.81 | 3.30 | 2.15 | 2.22 | 2.78 |
Yield(%) | 1.27 | - | - | - | - |
EV/Net Sales(x) | 3.02 | 3.54 | 2.37 | 2.82 | 3.60 |
EV/Core EBITDA(x) | 15.33 | 15.64 | 14.07 | 13.06 | 11.13 |
EV/EBIT(x) | 17.60 | 17.20 | 16.16 | 14.72 | 12.27 |
EV/CE(x) | 2.79 | 3.28 | 2.13 | 2.19 | 2.75 |
M Cap / Sales | 3.05 | 3.56 | 2.39 | 2.84 | 3.62 |
Growth Ratio | |||||
Net Sales Growth(%) | 8.50 | 8.92 | 16.74 | 14.61 | -0.82 |
Core EBITDA Growth(%) | -5.61 | 46.32 | -8.78 | -23.50 | 19.14 |
EBIT Growth(%) | -9.63 | 52.83 | -10.46 | -25.23 | 20.96 |
PAT Growth(%) | -12.55 | 57.39 | -10.33 | -28.23 | 25.56 |
EPS Growth(%) | -12.55 | 60.21 | -8.77 | -28.19 | 27.23 |
Financial Stability Ratios | |||||
Total Debt/Equity(x) | - | - | - | - | - |
Current Ratio(x) | 2.31 | 2.22 | 1.98 | 2.05 | 2.17 |
Quick Ratio(x) | 1.63 | 1.59 | 1.53 | 1.61 | 1.82 |
Interest Cover(x) | 80.21 | 99.22 | 64.07 | 94.67 | 113.90 |
Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of FDC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
FDC | ₹7,553.9 Cr | 1.3% | -2.6% | -14.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹378,999.0 Cr | -0.4% | -3% | -14.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹163,635.0 Cr | 0.6% | -3.1% | 20.2% | Stock Analytics | |
CIPLA | ₹127,544.0 Cr | 0% | 5.2% | -5.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,050.0 Cr | 0.8% | -1.9% | 2.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,373.0 Cr | 0.1% | 3.5% | -10.6% | Stock Analytics |
FDC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
FDC | 1.3% |
-2.6% |
-14.6% |
SENSEX | -0.3% |
-0.8% |
-1.9% |
You may also like the below Video Courses